巨细胞通过前列腺素E驱动的可溶性ST2控制2型肺炎
Kinan Alhallak1, Jun Nagai1, Kendall Zaleski2
1Departments of Medicine and Pediatrics, Harvard Medical School, Boston, MA, USA; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, USA.
Immunity
|May 31, 2024
概括
前列腺素E2 (PGE2) 刺激巨细胞产生可溶性ST2 (sST2),一种限制2型炎症 (T2I) 的蛋白质. 这一发现解释了在低PGE2水平的条件下严重的T2I.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 炎症研究 炎症研究
背景情况:
- 严重的喘和鼻疾病与2型炎症 (T2I) 有关.
- 通过其受体ST2传递信号的互乐-33 (IL-33) 介导T2I.
- 可溶性ST2 (sST2) 限制了T2I,但其调节的理解很少.
研究的目的:
- 调查前列腺素E2 (PGE2) 在调节sST2产生中的作用.
- 阐明 PGE2 影响 T2I 的机制.
- 了解PGE2,sST2和严重呼吸道T2I之间的联系.
主要方法:
- 使用了缺少PGE2的小鼠模型.
- 在血清和肺组织中评估sST2水平.
- 研究了巨细胞 (MCs) 和Eprostanoid (EP) 2受体在sST2产生中的作用.
- 在小鼠模型中给予重组sST2.
主要成果:
- 在小鼠中,PGE2缺乏导致sST2水平降低和T2I恶化.
- PGE2增强了巨细胞的sST2分泌.
- 缺乏乳腺细胞,乳腺细胞上的ST2或乳腺细胞上的EP2受体的小鼠显示sST2降低和T2I增加.
- 再组合的sST2改善了小鼠的T2I,这些小鼠患有PGE2缺乏症或在巨细胞上缺乏ST2.
结论:
- PGE2驱动着巨细胞的sST2产生,从而抑制T2I.
- 这种机制解释了在低PGE2状态下严重的T2I.
- 准PGE2-sST2-杆细胞轴可能为严重喘和鼻疾病提供治疗策略.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271
01:20Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
01:38Inflammation
53.3K
Overview
53.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
420
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
420